Division of Vascular Surgery, Department of Surgery and Knight Cardiovascular Institute, School of Medicine, Oregon Health & Science University, Portland, OR.
Research & Development and Operative Care Division, Veterans Affairs Portland Health Care System, Portland, OR.
J Vasc Surg Venous Lymphat Disord. 2023 Jul;11(4):774-782.e1. doi: 10.1016/j.jvsv.2023.03.013. Epub 2023 Apr 6.
Obesity is highly prevalent and a major risk factor for deep vein thrombosis (DVT) and chronic venous disease. It can also technically limit duplex ultrasound evaluations for lower extremity DVT. We compared the rates and results of repeat lower extremity venous duplex ultrasound (LEVDUS) after an initial incomplete and negative (IIN) LEVDUS in overweight (body mass index [BMI] ≤25-30 kg/m) and obese (BMI ≥30 kg/m) patients with those of patients with a BMI <25 kg/m to evaluate whether increasing the rate of follow-up examinations in overweight and obese patients might facilitate improved patient care.
We performed a retrospective review of 617 patients with an IIN LEVDUS study from December 31, 2017 to December 31, 2020. Demographic and imaging data of the patients with an IIN LEVDUS and the frequency of repeat studies performed within 2 weeks were abstracted from the electronic medical records. The patients were divided into three BMI-based groups: normal (BMI <25 kg/m), overweight (BMI 25-30 kg/m), and obese (BMI ≥30 kg/m).
Of the 617 patients with an IIN LEVDUS, 213 (34.5%) were normal weight, 177 (29%) were overweight, and 227 (37%) were obese. The repeat LEVDUS rates were significantly different across the three weight groups (P < .001). After an IIN LEVDUS, the rate of repeat LEVDUS for the normal weight, overweight, and obese groups was 46% (98 of 213), 28% (50 of 227), and 32% (73 of 227), respectively. The overall rates of thrombosis (both DVT and superficial vein thrombosis) in the repeat LEVDUS examinations were not significantly different among the normal weight (14%), overweight (11%), and obese (18%) patients (P = .431).
Overweight and obese patients (BMI ≥25 kg/m) received fewer follow-up examinations after an IIN LEVDUS. Follow-up LEVDUS examinations of overweight and obese patients after an IIN LEVDUS study have similar rates of venous thrombosis compared with normal weight patients. Targeting improving usage of follow-up LEVDUS studies for all patients, but especially for those who are overweight and obese, with an IIN LEVDUS through quality improvement efforts could help minimize missed diagnoses of venous thrombosis and improve the quality of patient care.
肥胖是深静脉血栓形成(DVT)和慢性静脉疾病的高发危险因素,也是下肢 DVT 双功能超声(LEVDUS)技术评估的限制因素。本研究比较了超重(BMI 为 25-30kg/m2)和肥胖(BMI ≥30kg/m2)患者与 BMI<25kg/m2 患者初始不完全和阴性(IIN)LEVDUS 后重复 LEVDUS 的频率和结果,以评估增加超重和肥胖患者的随访检查率是否有助于改善患者的治疗效果。
我们对 2017 年 12 月 31 日至 2020 年 12 月 31 日期间 617 例 IIN LEVDUS 研究的患者进行了回顾性分析。从电子病历中提取 IIN LEVDUS 患者的人口统计学和影像学数据以及在 2 周内进行重复检查的频率。患者根据 BMI 分为三组:正常体重组(BMI<25kg/m2)、超重组(BMI 为 25-30kg/m2)和肥胖组(BMI≥30kg/m2)。
617 例 IIN LEVDUS 患者中,213 例(34.5%)为正常体重,177 例(29%)为超重,227 例(37%)为肥胖。三组患者的重复 LEVDUS 率差异有统计学意义(P<0.001)。在 IIN LEVDUS 后,正常体重、超重和肥胖组的重复 LEVDUS 率分别为 46%(98/213)、28%(50/227)和 32%(73/227)。重复 LEVDUS 检查中深静脉血栓形成(DVT 和浅静脉血栓形成)的总发生率在正常体重组(14%)、超重组(11%)和肥胖组(18%)之间差异无统计学意义(P=0.431)。
超重和肥胖患者(BMI≥25kg/m2)在 IIN LEVDUS 后接受的随访检查较少。与正常体重患者相比,IIN LEVDUS 研究后超重和肥胖患者的重复 LEVDUS 检查中静脉血栓形成的发生率相似。通过质量改进措施,针对所有患者,尤其是超重和肥胖患者,提高 IIN LEVDUS 的重复 LEVDUS 检查使用率,有助于减少静脉血栓形成的漏诊,提高患者的治疗效果。